# NIH Reporter #1R01HD122219-01

The Benefits, Risks, and Long-term Impact of GLP-1 Receptor Agonists in Children

**Recipient:** Indiana University Indianapolis

**Award Amount:** $1,589,979.00
**Ceiling:** $1,589,979.00

**Awarded:** September 17, 2026

**Identifier:** 1R01HD122219-01

The project will use electronic health records, insurance claims, and other real-world data to study the effects of GLP-1 receptor agonists in children aged 10–18 with obesity or type 2 diabetes. It will develop computable phenotypes, evaluate treatment outcomes and safety, and build a microsimulation model of long-term health outcomes and costs.

### Description

NIH-funded project to develop a framework for evaluating the benefits and risks of GLP-1 receptor agonist use in children, using real-world data to assess clinical, mental health, developmental, and long-term outcomes.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11357531)